David A. Preston

2.9k total citations
95 papers, 2.3k citations indexed

About

David A. Preston is a scholar working on Molecular Biology, Pharmacology and Infectious Diseases. According to data from OpenAlex, David A. Preston has authored 95 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Pharmacology and 14 papers in Infectious Diseases. Recurrent topics in David A. Preston's work include Antibiotic Resistance in Bacteria (14 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Antimicrobial Resistance in Staphylococcus (12 papers). David A. Preston is often cited by papers focused on Antibiotic Resistance in Bacteria (14 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Antimicrobial Resistance in Staphylococcus (12 papers). David A. Preston collaborates with scholars based in United States, United Kingdom and Malaysia. David A. Preston's co-authors include Changbu Wu, Norris E. Allen, William E. Alborn, W. E. Wick, J E Flokowitsch, Thalia I. Nicas, Gary V. Doern, Mark G. Macklin, JoAnn Hoskins and Paul L. Skatrud and has published in prestigious journals such as The Science of The Total Environment, Clinical Infectious Diseases and Journal of Bacteriology.

In The Last Decade

David A. Preston

86 papers receiving 2.0k citations

Peers

Countries citing papers authored by David A. Preston

Since Specialization

Citations

This map shows the geographic impact of David A. Preston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Preston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Preston more than expected).

Fields of papers citing papers by David A. Preston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Preston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Preston. The network helps show where David A. Preston may publish in the future.

Co-authorship network of co-authors of David A. Preston

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Preston. A scholar is included among the top collaborators of David A. Preston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Preston. David A. Preston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Policy approaches to increase external investment by US pension funds in African countries 2024 ·Global Policy ·David A. Preston	0
2	Heavy metal contamination of water, soil and produce within riverine communities of the Rıo Pilcomayo basin, Bolivia 2003 ·The Science of The Total Environment ·Jerry R. Miller, Karen A. Hudson‐Edwards, Paul J. Lechler, David A. Preston, Mark G. Macklin	162
3	Antibiotic Susceptibilities Among Recent Clinical Isolates of Haemophilus influenzae and Moraxella catarrhalis from Fifteen Countries 2001 ·European Journal of Clinical Microbiology & Infectious Diseases ·Stephen I. Bandak, (unknown), Bradley S. Allen, (unknown), David A. Preston, S. Bouchillon, D. J. Hoban	18
4	Assessment of the Susceptibility ofStreptococcus pneumoniaeto Cefaclor and Loracarbef in 13 Countries 2000 ·Journal of Chemotherapy ·Stephen I. Bandak, (unknown), Bradley S. Allen, (unknown), David A. Preston	3
5	Synthesis of new 3-thiosubstituted carbacephem antibiotics and their activity against penicillin resistant Streptococcus pneumoniae 1997 ·Bioorganic & Medicinal Chemistry Letters ·Larry C. Blaszczak, (unknown), J E Flokowitsch, (unknown), Stephen A. Hitchcock, (unknown), (unknown), (unknown), David A. Preston, Mohammad Zia‐Ebrahimi	1
6	Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci. 1996 ·The Journal of Antibiotics ·Thalia I. Nicas, DEBORAH L. MULLEN, J E Flokowitsch, David A. Preston, Nancy Snyder, Mark J. Zweifel, Stephen C. Wilkie, Michael Rodriguez, R. C. Thompson, (unknown)	18
7	Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria 1995 ·Antimicrobial Agents and Chemotherapy ·Thalia I. Nicas, DEBORAH L. MULLEN, J E Flokowitsch, David A. Preston, Nancy Snyder, Robert E. Stratford, Robert D. Cooper	45
8	Synthesis and in Vitro Evaluation of New Cephalosporins Exhibiting Antimicrobial Activity against Gram‐Positive Bacteria, in Particular Methicillin‐Resistant Staphylococci 1995 ·Journal of the Chinese Chemical Society ·Ho‐Shen Lin, (unknown), J E Flokowitsch, William E. Alborn, (unknown), David A. Preston	2
9	Discovery and structure-activity relationship of a series of 1-carba-1-dethiacephems exhibiting activity against methicillin-resistant Staphylococcus aureus 1993 ·Journal of Medicinal Chemistry ·Robert J. Ternansky, Susan E. Draheim, Andrew Pike, (unknown), Sarah J. West, Christopher L. Jordan, Changbu Wu, David A. Preston, William E. Alborn	27
10	In-vitro synergy and mechanism of interaction between vancomycin and ciprofloxacin against enterococcal isolates 1993 ·Journal of Antimicrobial Chemotherapy ·Serhat Ünal, J E Flokowitsch, DEBORAH L. MULLEN, David A. Preston, Thalia I. Nicas	15
11	Synthesis, hydrolysis rates, supercomputer modeling, and antibacterial activity of bicyclic tetrahydropyridazinones 1991 ·Journal of Medicinal Chemistry ·Louis N. Jungheim, Donald B. Boyd, Joseph M. Indelicato, (unknown), David A. Preston, William E. Alborn	28
12	A54145 a new lipopeptide antibiotic complex. Microbiological evaluation. 1990 ·The Journal of Antibiotics ·F. T. COUNTER, Norris E. Allen, D. S. Fukuda, J N Hobbs, J. L. OTT, P. W. Ensminger, Jon S. Mynderse, David A. Preston, Changbu Wu	43
13	Antibacterial properties of the bicyclic pyrazolidinones. 1990 ·The Journal of Antibiotics ·Norris E. Allen, J N Hobbs, David A. Preston, J. R. Turner, Changbu Wu	25
14	Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis 1989 ·Antimicrobial Agents and Chemotherapy ·Thalia I. Nicas, Changbu Wu, J N Hobbs, David A. Preston, Norris E. Allen	91
15	Susceptibility of multiply resistant Haemophilus influenzae to newer antimicrobial agents 1988 ·Diagnostic Microbiology and Infectious Disease ·J H Jorgensen, Gary V. Doern, Clyde Thornsberry, David A. Preston, J S Redding, L A Maher, (unknown)	30
16	Microbiological aspects of erythromycin 1986 ·The Pediatric Infectious Disease Journal ·David A. Preston	8
17	Evaluation of water resources for enhanced oil recovery operations, Cement Field, Caddo and Grady Counties, Oklahoma 1982 ·OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) ·David A. Preston, (unknown), (unknown), (unknown), (unknown)	1
18	Emigracion rural y desarrollo agricola en la sierra ecuatoriana 1981 ·David A. Preston, (unknown), Richard A. Preston	1
19	Rural-urban and inter-settlement interaction: theory and analytical structure 1975 ·Area ·David A. Preston	23
20	Rural Emigration in Andean America 1969 ·Human Organization ·David A. Preston	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact